BioSpace News Archive

FDA

Masimo Announces CE Marking and Release of Oxygen Reserve Index rainbow Lite Sensors

ORi is the first noninvasive and continuous parameter to provide insight into a patient’s oxygen reserve in the moderate hyperoxic range.

January 2, 2018
·
8 min read
Medivir’s Series A Shares to be Converted Into Series B Shares

The conversion will be completed as soon as possible following the Extraordinary General Meeting in Medivir to be held on 26 January 2018.

January 2, 2018
·
2 min read
Business

J&J Announces Quarterly Dividend for First Quarter 2018

J&J today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company’s common stock.

January 2, 2018
·
1 min read
Pharm Country

Soligenix Announces U.S. Patent Issuance for Use of Dusquetide in Oral Mucositis

Soligenix announced today that the U.S. Patent Office has granted the patent entitled “Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis.”

January 2, 2018
·
9 min read
The Medivir Board is Seeking Issue Authorizations to Increase the Company’s Funding Flexibility and Calls for an Extraordinary General Meeting

Medivir today announces a notice for an Extraordinary General Meeting, to be held on 26 January 2018, with a proposal for the Meeting to authorize the Board of Directors to resolve on a directed share issue of not more than 20 percent of the number of shares of series B.

January 2, 2018
·
3 min read
Biotech Beach

KARL STORZ Receives Innovative Technology Designation From Vizient for VITOM 3D System

KARL STORZ announced that its VITOM 3D system for visualization in microsurgery and open surgical procedures has received a 2017 Innovative Technology designation from Vizient, Inc.

January 2, 2018
·
4 min read
Business

Teleflex Completes Previously Announced CEO Transition

Effective January 1, 2018, Liam Kelly, who previously served as Teleflex’s President and Chief Operating Officer, assumed the position of President and Chief Executive Officer.

January 2, 2018
·
2 min read
Galmed Pharma Raised Gross Proceeds of $11.6M Under ATM Programs During December 2017

The Company issued 1,368,667 ordinary shares under its former and existing ATM programs during December 2017 at an average sale price of $8.45 per share.

January 2, 2018
·
5 min read
Deals

Nuvo Pharma Acquires Global Ex-U.S. Product Rights and Existing Royalty Streams to Resultz From Piedmont Pharma

The transaction includes existing royalty streams in the Royalty Markets and all product and intellectual property rights in the Territory.

January 2, 2018
·
7 min read
FDA

Merck’s KEYTRUDA (pembrolizumab) Approved in Japan for Use in the Treatment of Patients with Urothelial Carcinoma That is Unresectable with Radical Surgery Who Have Progressed Following Cancer Chemotherapy

today announced that KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) for the treatment of patients with radically unresectable urothelial carcinoma who progressed after cancer chemotherapy.

January 2, 2018
·
26 min read